Factom is the first usable blockchain technology to solve real-world business problems by providing an unalterable record-keeping system. By creating a data layer on top of the Bitcoin blockchain, Factom’s distributed ledger technology secures millions of real-time records in the blockchain with a single hash using cryptographic isolation. Businesses and governments alike can use Factom to document their information so that it cannot be modified, deleted or backdated. Factom’s technology decentralizes record keeping by ensuring that the integrity of stored data remains intact, providing complete transparency, while at the same time maintaining user privacy in an increasingly digital world. The Factom project began in 2014 which puts it on the older end of the blockchain spectrum. The team has made steady progress since then. They released the first version of Factom in early 2015 and had their token sale in the middle of that year. In August of 2015, they were accepted into the Plug and Play FinTech accelerator and were chosen as one of Austin’s A-List start-ups in May 2016. Based out of Austin, TX, the core team has multiple members with several years of experience in the blockchain space. Peter Kirby, Factom Co-founder and CEO, and Abhi Dobhal, VP Product Management, previously worked together at CoinTerra, Inc – a producer of ASIC miners for Bitcoin. The price of a Factoid is directly tied to the amount of network usage. As more businesses join the network, it will become more costly to submit Entries which will, in turn, affect the Factoid price. Once the number of Factoids being burned outpaces the 73,000 that are created each month, the currency will become deflationary. This may drive the price up even further.
'Humanscape is a decentralized patient network based on blockchains. Humanscape can provide practical help for patients to overcome their diseases through intellectual and emotional interaction with each other based on community activities. This process is expected to generate and collect a high volume of patient data, namely PGHD, on various disease groups in our data hub. Furthermore, Humanscape facilitates active research into incurable diseases and the development of new drugs by linking patients to external industry sectors such as pharmaceutical firms and research institutes and helps patients to avoid complications and enjoy healthy lives through the continuous self-management of their lifestyle and symptoms. Data being stored on blockchain, no third party can monopolize health data and profit made out PGHD will be returned to patients. With these services, Humanscape is taking steps to liberate patients from incurable diseases, as its contribution to a world where everyone is healthy.'